Genetic characterisation of invasive breast cancer: A comparison of CGH and PCR based multiplex microsatellite analysis

Journal of Clinical Pathology

Volumn 54, Issue 11, 2001, Pages 836-840

  Buerger, H ^a   Schmidt, H ^b   Beckmann, A ^b   Zanker K S ^c   Boecker, W ^a   Brandt, B ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Breast cancer; Comparative genomic hybridisation; Epidermal growth factor; Microsatellites; P53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICROSATELLITE DNA; PROTEIN P53;

ALLELE; ARTICLE; BREAST CANCER; CANCER INVASION; CELL COUNT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EVALUATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TECHNIQUE; TUMOR CELL;

EID: 0035173193     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.11.836     Document Type: Article

References (20)

1. Comparative genomic hybridization of ductal carcinoma in situ of the breast - Evidence of multiple genetic pathways
2. Molecular cytogenetics of primary breast cancer by CGH
3. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals
4. Minimal sizes of deletions detected by comparative genomic hybridization
5. 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast
6. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS
7. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and EGFR-expression
8. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
9. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
10. Semiautomated assessment of loss of heterozygosity and replication error in tumors
11. Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content
12. Genetic instabilities in human cancers
13. Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization
14. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast
15. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast
16. 17q21-q25 aberrations in breast cancer: Combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification
17. At least five regions of imbalance on 6q in breast tumors, combining losses and gains
18. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation
19. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer
20. Distinct deletions in the egfr gene enhancing transcription force tumor growth in breast carcinogenesis